Victory Science & Technology Fund (USSCX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in equity securities of companies expected to benefit from scientific and technological advances and improvements; it normally allocates at least 80% of its assets to such domestic and foreign equities, including up to 50% in non-U.S. securities from emerging markets, across sectors like biotechnology, software, semiconductors, and internet services. The fund targets growth-oriented investors with a higher risk tolerance, suitable for the aggressive portion of a diversified portfolio, and features holdings in both established large-cap leaders and innovative smaller companies principally operating in the United States, with secondary exposure to international markets. Launched in August 1997 and headquartered in Columbus, Ohio under Victory Capital Management Inc., the fund manages approximately $1.4 billion in assets with a net expense ratio of 0.96%.
In recent years, the fund underwent a significant rebranding from USAA Science & Technology Fund to its current name as part of Victory Capital's broader transition of the USAA Mutual Funds lineup, completed in early 2023 with no changes to investment objectives, management teams, or processes; this followed Victory Capital's 2019 acquisition of USAA Asset Management Company. Victory Capital further expanded through its April 2024 agreement to acquire Amundi US, closed in early 2025, enhancing scale to nearly $300 billion in assets under management and adding diversified U.S. investment capabilities while Amundi became a strategic shareholder. These developments strengthen the fund's position within Victory Capital's multi-boutique platform, which emphasizes technology sector expertise via the Trivalent Investments franchise.